This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
We bring deep experience managing these challenges to each Cell and Gene Therapy (CGT) engagement, supported by the Syneos Health Cell and Gene Therapy Consortium, the hub for our knowledge and
Interview With A CRA About Differences Working for Sponsor and CRO In this episode I interview a CRA and friend of mine about the differences of working for a Contract Research Organization (CRO) and a Sponsor. We dive into the differences between working for a company like Johnson and Johnson or Roche versus a company like Parexel or IQVIA. What are the challenges that a CRA might face.
One of our clients, the Belarus Republican Scientific and Technical Library recently posted an article on how they support innovation. They open with the statement that “The novelty, effectiveness and…. The post Customer Success: DrugPatentWatch for Your Library appeared first on DrugPatentWatch - Make Better Decisions.
On behalf of Prescription Justice, I submitted comments to the FDA in response to its request for public comments on its draft guidance called: “Importation of Certain FDA-Approved Human Prescription Drugs, Including Biological Products, under Section 801(d)(1)(B) of the Federal Food, Drug, and Cosmetic Act: Draft Guidance for Industry.”. I published the comments in their entirety on Prescription Justice here: [link].
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Interview With A CRA About Differences Working for Sponsor and CRO In this episode I interview a CRA and friend of mine about the differences of working for a Contract Research Organization (CRO) and a Sponsor. We dive into the differences between working for a company like Johnson and Johnson or Roche versus a company like Parexel or IQVIA. What are the challenges that a CRA might face.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content